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Abstract
Chlorophyllin (CHL), a water-soluble, semi-synthetic derivative of chlorophyll and ellagic acid (EA), a naturally occurring
polyphenolic compound in berries, grapes, and nuts have been reported to exert anticancer effects in various human cancer
cell lines and in animal tumour models. The present study was undertaken to examine the mechanism underlying
chemoprevention and changes in gene expression pattern induced by dietary supplementation of chlorophyllin and ellagic
acid in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model by whole
genome profiling using pangenomic microarrays. In hamsters painted with DMBA, the expression of 1,700 genes was found
to be altered significantly relative to control. Dietary supplementation of chlorophyllin and ellagic acid modulated the
expression profiles of 104 and 37 genes respectively. Microarray analysis also revealed changes in the expression of TGFb
receptors, NF-kB, cyclin D1, and matrix metalloproteinases (MMPs) that may play a crucial role in the transformation of the
normal buccal pouch to a malignant phenotype. This gene expression signature was altered on treatment with
chlorophyllin and ellagic acid. Our study has also revealed patterns of gene expression signature specific for chlorophyllin
and ellagic acid exposure. Thus dietary chlorophyllin and ellagic acid that can reverse gene expression signature associated
with carcinogenesis are novel candidates for cancer prevention and therapy.
Citation: Vidya Priyadarsini R, Kumar N, Khan I, Thiyagarajan P, Kondaiah P, et al. (2012) Gene Expression Signature of DMBA-Induced Hamster Buccal Pouch
Carcinomas: Modulation by Chlorophyllin and Ellagic Acid. PLoS ONE 7(4): e34628. doi:10.1371/journal.pone.0034628
Editor: Abdelilah Aboussekhra, King Faisal Specialist Hospital & Research Center, Saudi Arabia
Received December 12, 2011; Accepted March 2, 2012; Published April 2, 2012
Copyright:  2012 Vidya Priyadarsini et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant from the Department of Biotechnology, New Delhi, India, under the 7th FP of the Indo-EU Joint Collaborative
Project on ‘FUNCFOOD’. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: s_nagini@yahoo.com
Introduction
Chemoprevention by natural products, dietary, and lifestyle
changes has evolved as a promising strategy in the management of
cancer. Dietary phytochemicals have gained significant recogni-
tion in recent years as potential candidates for cancer chemopre-
vention owing to their ability to arrest or reverse the cellular and
molecular processes associated with carcinogenesis [1]. Chlor-
ophyllin (CHL), a water-soluble, semi-synthetic derivative of
chlorophyll, and ellagic acid (EA), a naturally occurring polyphe-
nolic compound in berries, grapes, and nuts have been reported to
exert potent antimutagenic and anticarcinogenic effects [2–4].
The anticarcinogenic effects of chlorophyllin have been
attributed to its ability to scavenge reactive oxygen species and
form complexes with planar carcinogens [2]. The anticancer
activity of chlorophyllin first demonstrated in the rainbow trout
was subsequently documented in several animal tumor models [5].
Chlorophyllin has also been reported to exhibit antiproliferative
effects in colon, breast, and leukemic cancer cell lines [6–8].
Human intervention trials with chlorophyllin showed a decrease in
aflatoxin-DNA adducts in individuals at high risk for liver cancer
[9].
Dietary ellagic acid either independently or synergistically is
responsible for a plethora of health beneficial effects. Ellagic acid
displays antimutagenic and anticarcinogenic effects against a
variety of carcinogens including nitrosamines, azoxymethane,
mycotoxins, and polycyclic aromatic hydrocarbons [10–13].
Ellagic acid also exerts anticancer effects in various human cancer
cell lines and in animal tumour models and has been found to
function as both a blocking and suppressing agent in carcinogen-
esis [14–18].
Despite the profuse epidemiological data, and studies on cell
and animal models, the mechanism underlying chemoprevention
and changes in gene expression pattern induced by chlorophyllin/
ellagic acid has remained largely unexplored. The present study
was undertaken to identify the genes that are differentially
modulated by treatment with chlorophyllin/ellagic acid during
7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal
pouch (HBP) carcinogenesis, an ideal animal model for analyzing
the effects of putative chemopreventive agents [19]. To this end,
we examined whole-genome expression using pangenomic micro-
arrays to unveil the molecular mechanisms and signaling pathways
regulated by chlorophyllin and ellagic acid.
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Body weight, tumour incidence, and histopathological
changes
The mean final body weights were significantly decreased in
group 1 (DMBA) compared to control (group 4). No significant
differences in the body weights were observed in group 2 and 3
animals. In group 1 animals, the incidence of SCC was 100% with
a tumour multiplicity of 2.6 per hamster. These tumours were
large and exophytic with a mean tumour burden of 77.32 mm
3.
No tumours were observed in group 2 (DMBA+chlorophyllin) and
group 3 (DMBA+ellagic acid) animals. Histopathological exami-
nation of these pouches revealed mild to moderate hyperplasia. In
group 4 animals, the epithelium was normal, intact, and
continuous. The gross appearance and representative photomi-
crographs of histopathological changes in the buccal pouch
mucosa of control and experimental animals are shown in Figure 1.
Differentially expressed genes
Analysis of microarray data revealed differential expression of
13,277 genes in DMBA painted hamsters relative to control. In
hamsters supplemented with chlorophyllin and ellagic acid in the
diet, 3,899 and 1,420 genes were differentially expressed relative to
control. Using a P value=0.05 and fold change cut off of 2,
differentially expressed genes were identified between DMBA,
DMBA+chlorophyllin, DMBA+ellagic acid groups by Imfit and
eBayes (Empirical Bayes method). We found that 1,700 genes were
differentially expressed in DMBA (Table S1); 104 genes in
DMBA+chlorophyllin (Table S2); and 37 genes in DMBA+ellagic
acid treated groups relative to control (Table S3). Venn diagram
analysis of the differentially regulated genes indicated that 64
genes were commonly regulated in DMBA and DMBA+chlor-
ophyllin, and 27 genes in DMBA and DMBA+ellagic acid groups.
Furthermore, 27 genes were identified to be universally regulated
by both chlorophyllin and ellagic acid (Figure 2). The microarray
data has been deposited in NCBI’s Gene Expression Omnibus
(GEO) with GEO series accession number GSE29679. Heat map
diagrams of differentially expressed genes in DMBA, DMBA+
chlorophyllin, and DMBA+ellagic acid groups are shown in
Figure 2.
Hierarchical clusters and molecular pathways modulated
Gene enrichment analysis using GSEA Pre Ranked Tool
revealed that 67 pathways were significantly dysregulated in
DMBA painted hamsters. The major functional categories of the
up-regulated genes in DMBA painted animals were associated
with cell cycle, TGFb signalling, and other signal transduction
cascades, whereas the most significantly downregulated gene
functions were associated with cell adhesion and apoptosis
(Table 1). Dietary administration of chlorophyllin and ellagic acid
were found to universally modulate expression of genes associated
with cell adhesion, cell-cell communication, and TGFb signaling
(Table 2).
Validation of microarray results by qPCR and Western
blot analysis
We performed quantitative reverse transcriptase PCR (qRT-
PCR) and western blot analysis to validate the results of
microarray analysis (Figures 3, 4, 5). A significant increase in the
expression of TGFRI, TGFRII, Smad7, NF-kB p50, NF-kB p65,
MMP-2, MMP-9, and cyclin D1, with decrease in the expression
of TIMP-2 was found in DMBA painted pouches compared to
control. Dietary supplementation of chlorophyllin and ellagic acid
to DMBA painted hamsters significantly downregulated both the
mRNA and protein expression of TGFRII, Smad7, NF-kB,
MMP-2, MMP-9, and cyclin D1 compared to group 1 animals
confirming the results of microarray analysis. Although immuno-
blot analysis revealed significant modulatory effects of both the
phytochemicals on protein expression of TGFRI and TIMP-2, the
qRT-PCR data indicated significant changes only for the
chlorophyllin supplemented group.
Discussion
A substantial number of studies have demonstrated the
chemopreventive efficacy of chlorophyllin and ellagic acid in
various animal tumour models [16–18,20,21]. We report for the
first time the inhibition of DMBA-induced HBP carcinogenesis by
dietary supplementation of chlorophyllin and ellagic acid based on
reduced incidence of preneoplastic and neoplastic lesions, and
changes in the expression pattern of genes associated with
carcinogenic signaling.
Figure 1. Gross appearance (A) and photomicrographs of histopathological changes (B) in the buccal pouch mucosa of control and
experimental animals (620).
doi:10.1371/journal.pone.0034628.g001
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expression of a substantial number of gene transcripts in HBP
tumours with a fold change greater than 2. Dietary administration
of chlorophyllin and ellagic acid significantly reversed the
expression of a subset of differentially expressed genes in DMBA
painted animals towards normal, suggesting that these genes may
Figure 2. Gene expression profiles in various experimental groups. (A) Venn diagram analysis of the differentially expressed genes with P
value=0.05 and two fold change cut off in various experimental groups. (B) Heat maps depicting the gene expression profiles of hamsters treated
with DMBA (B1), DMBA+chlorophyllin (B2) and DMBA+ellagic acid (B3). The heat map represents unsupervised clustering of differentially-expressed
genes (P value=0.05, fold change cut off of 2) using Imfit and eBayes (Empirical Bayes) method. Heat map values are log2-transformed, normalized
fluorescence ratios of control versus treatment groups. Red represents an expression level above the mean expression of a gene across all samples;
black represents mean expression; green indicates expression lower than the mean.
doi:10.1371/journal.pone.0034628.g002
Table 1. Molecular pathways related to the genes differentially expressed in DMBA painted animals.
Functional classification Genes Symbols
DMBA- upregulated
HSA04110_Cell cycle CCNB1, CCND1, CCND3, TGFB1, PCNA, CDK7
HSA04512_ECM receptor interaction COL5A3, COL5A1, THBS4, CD44, TNR
HSA05219_Bladder cancer MMP9, MMP2, EGFR
HSA04630_JAK STAT signaling pathway JAK2, PTPN6, STAT1, CCND3
HSA04670_Leukocyte trans endothelial migration MMP9, MMP2, ACTN1, CYBA, CXCL12
HSA04510_Focal adhesion COL5A3, EGFR, PDGFRB, MAPK8, CCND1, JUN, TNR, SRC
HSA05222_Small cell lung cancer CCNE1, NOS3, CCND1, NFKB1
HSA04350_TGF beta signaling pathway TGFB1, SMAD7, THBS4
DMBA- downregulated
HSA03320_PPAR signaling pathway FABP3, HMGCS2, ACSL6, ME1
HSA04530_Tight junction MYH2, MYH6, OCLN, PPP2R2A, PRKCH, F11R, PARD3
HSA04520_Adherens junction LMO7, PARD3, ACTN4, ERBB2
HSA04514_Cell adhesion molecules NRXN1, OCLN, CDH15, CLDN1, L1CAM
HSA04210_Apoptosis CAPN1, PIK3R1, PPP3CA, PRKAR1A, CHP
Gene enrichment analysis for the up- and down-regulated genes was done using GSEA Pre Ranked Tool. The selection criteria were set at Benjamin-Hochberg P=0.05.
Only statistically significant pathways showing a permuted P-value=0.05 and a positive (enrichment) z-score .2 were selected.
doi:10.1371/journal.pone.0034628.t001
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phytochemicals. In particular, downregulation of TGFb receptors,
Smad7, MMPs, cyclin D1, and NF-kB by chlorophyllin and
ellagic acid may play a key role in impeding the development of
HBP tumours.
Of late, TGF-b has emerged as a promising therapeutic target
against cancer and several small and large-molecule compounds
that block TGF-b signalling have entered clinical trials [22,23].
TGF-b, a multifunctional cytokine regulates a diverse array of
cellular processes including morphogenesis, motility, differentia-
tion, cell proliferation, apoptosis, and invasion in various cell types.
TGF-b signalling is mediated through two serine/threonine kinase
transmembrane receptors, TbRI and RII that activate Smads.
Activated Smads relocate to the nucleus and together with other
transcription factors regulate the expression of target genes [24].
TGF-b plays a dual role in oncogenesis, functioning as a tumor
suppressor in early stages of tumour development and as an
oncogene in later stages [25]. Downregulation of TbRI and RII as
well as Smad-7 by chlorophyllin and ellagic acid supports the view
that tumors in which TGF-b functions as an oncogenic factor are
good candidates for anti-TGF-b therapy.
Modulation of TGFb signaling by chlorophyllin and ellagic acid
was associated with downregulation of nuclear factor-kappa B (NF-
kB). Strategies that target NF-kB, a hub in oncogenic signaling are
considered central in designing effective anticancer agents [26,27].
NF-kB, a redox-sensitive transcription factor functions as a major
mediator of inflammation, cell cycle progression, cell survival, and
metastasis during carcinogenesis. In unstimulated cells, NF-kB
exists in the cytosol as an inactive heterodimer of p50 and p65
subunits complexed to inhibitor of NF-kB( I kB). Upon stimulation,
IkB undergoes rapid phosphorylation by IkB kinase b (IKKb) and
degradation via the ubiquitin proteasome pathway. Dissociation of
IkB from the p50/p65 heterodimer exposes the nuclear localization
signals on NF-kB that subsequently translocates to the nucleus and
regulates the transcription of over 500 genes implicated in
oncogenesis [28,29]. In particular, transactivation of cyclin D1
and epithelial-mesenchymal transition (EMT) programming genes
such as matrix metalloproteinases (MMPs) by NF-kB is considered
critical for malignant transformation [30–32].
Cyclin D1, an oncogene that promotes cell cycle progression
through phosphorylation of the retinoblastoma protein and prevents
apoptosis by sequestering Bax in the cytoplasm has been recognized
as a potential therapeutic target in cancer [33,34]. Downregulation of
cyclin D1 by dietary supplementation of chlorophyllin and ellagic
acid may be attributed to abrogation of signaling through receptor
tyrosine kinases, and the MEK–ERK, WNT, and NF-kB pathways
as well as TGF-b mediated antiproliferative control [34].
The results of the present study suggest that deregulation of
TGFb/NF-kB signaling triggers upregulation of MMP-2 and -9 in
HBP carcinomas. Numerous studies have demonstrated a direct
link between TGFb/NF-kB signaling and MMP overexpression in
various cancers [35–38]. MMPs, a family of zinc-dependent
endopeptidases that catalyze the disintegration of the ECM and
basement membrane play a pivotal role in tumor invasion and
angiogenesis [39]. Despite the limited success of MMP inhibitors
in clinical trials, several pharmaceutical companies have invested
considerable efforts to develop safe and effective agents to target
MMPs [40]. Chlorophyllin and ellagic acid that decrease the
expression of MMP-2 and -9 are attractive candidates for
inhibiting MMPs and consequent tumor progression.
In summary, our results reveal multiple gene changes in
DMBA-induced HBP carcinomas. In particular, changes in the
expression of TGFb receptors, NF-kB, cyclin D1, and MMPs play
a crucial role in the transformation of the normal buccal pouch to
a malignant phenotype. Consistent with our findings, Yang et al.
[41] reported that 5,255 genes were differentially expressed during
the development and progression of HBP carcinomas most of
which were associated with cell structure, cell adhesion, cell
differentiation, signal transduction, and transcription regulation.
The ability of chlorophyllin and ellagic acid to modulate the
expression of these genes supports the notion that these
phytochemicals acid display chemopreventive efficacy by reversing
gene expression signature associated with tumorigenesis. Our
study has also revealed patterns of gene expressions that offer clues
for both the chemopreventive mechanism as well as molecular
gene expression signature specific for chlorophyllin and ellagic
acid exposure.
Over the last several years there has been an increasing focus on
developing anticancer agents that target multiple molecules or
pathways that are aberrant in cancer. Recent studies from this
laboratory and by others have demonstrated that ellagic acid and
chlorophyllin exert their anticancer effects by blocking DNA
damage, WNT and NF-kB signaling, and inducing apoptosis [42–
44]. Taken together our results indicate that dietary chlorophyllin
and ellagic acid that can simultaneously target several dysregulated
pathways and multiple molecules with pleiotropic effects and
reverse gene expression associated with carcinogenesis are novel
candidates for cancer prevention and therapy.
Materials and Methods
Chemicals
Chlorophyllin, ellagic acid, acrylamide, bovine serum albumin
(BSA), bromophenol blue, diethylpyrocarbonate (DEPC), DMBA,
Table 2. Molecular pathways related to the genes commonly modulated by chlorophyllin and ellagic acid supplementation.
Functional classification Genes Symbols
Chlorophyllin/Ellagic acid- upregulated
HSA04514_Cell adhesion molecules NRCAM, CLDN1, NRXN1
HSA03320_PPAR signaling pathway UBC, HMGCS2
Hsa04080_Neuroactive ligand receptor interaction OPRM1, P2RX2, GLP1R, EDG5, DRD4
Chlorophyllin/Ellagic acid- downregulated
HSA04350_TGF beta signaling pathway TGFB1
Hsa03050_Proteasome PSMA7
Genes commonly modulated by chlorophyllin and ellagic acid in the enriched pathways (z-score .2) are listed. Gene enrichment analysis was done using GSEA Pre
Ranked Tool. P value correction was done using Benjamini and Hochberg method.
doi:10.1371/journal.pone.0034628.t002
Chemopreventive Effects of CHL and EA
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e346282-mercaptoethanol, sodium dodecylsulphate (SDS), N,N,N9,N9-
tetramethylene diamine (TEMED), and trizol were purchased
from Sigma Chemical Company, St. Louis, MO, USA. All other
reagents used were of analytical grade. Power SYBRH Green PCR
master mix was purchased from Applied Biosystems, California,
USA. Oligonucleotide primers were purchased from Sigma
Genosys, San Ramon, USA. Primary and secondary antibodies
were purchased from Santa Cruz Biotechnology, USA.
Animals and diet
The experiment was carried out with male Syrian hamsters
aged 8–10 weeks weighing 100–110 g obtained from the Central
Animal House, Annamalai University, India. The animals housed
four to a polypropylene cage were provided with standard pellet
diet (Kamadhenu Agencies, Bengaluru, India) and water ad libitum
and maintained under controlled conditions of temperature and
humidity with an alternating light/dark cycle in accordance with
the guidelines of the Indian Council of Medical Research, and
approved by the ethical committee, Annamalai University
(approval ID-670).
Experimental design
The animals were randomized into experimental and control
groups and divided into 4 groups of eight animals each. In group
Figure 3. Transcript expression levels of TGFbRI, TGFbRII, Smad7, NF-kB p50, and NF-kB p65 in various experimental groups as
determined by RT-qPCR. cDNA individually generated from the buccal pouch RNA of biological replicates was subjected to RT-qPCR analysis.
Relative mRNA expression for each gene was determined and normalized to the average transcript expression of GAPDH internal control. The fold
change in transcript expression for each gene was determined using the 2
2DDCt method. Data are the mean 6 SD of two separate experiments.
Statistical significance was determined by Mann-Whitney test (P,0.05). a Significantly different from control. b Significantly different from DMBA.
doi:10.1371/journal.pone.0034628.g003
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cent solution of DMBA in liquid paraffin using a No.4 sable brush,
three times per week for 14 weeks as described earlier [45]. Group
2 and 3 animals painted with DMBA as in group 1, received
4 mg/kg bw of chlorophyllin and 0.4% of ellagic acid respectively
in the diet for 14 weeks. Group 4 animals received basal diet and
served as control. The doses of chlorophyllin and ellagic acid used
in this study were chosen based on a dose response study
undertaken by us that demonstrated maximum chemopreventive
efficacy at these doses as well as on previous reports [9,42,46,47].
The experiment was terminated at the end of 14 weeks and all
animals were sacrificed by cervical dislocation after an overnight
fast.
RNA extraction, microarray hybridization and data
analysis
Total RNA was isolated from the buccal pouch of two
individual hamsters in each experimental group using Trizol as
described previously [48]. Isolated RNA was then purified using
RNAeasy columns (Qiagen GmbH, Hilden, Germany) and treated
with ribonuclease free DNaseI to remove any contaminating
DNA. RNA was quantitated by NanoDrop ND-1000 (Thermo
Scientific, Wilmington DE) and the quantity and integrity was
established by resolving on 0.8% formaldehyde agarose gels.
Microarray experiments were performed in replicates using
Agilent Whole Rat Genome Oligo Microarray Kit, 4644 k. As
genome sequence information of hamsters are relatively limited,
rodent microarrays such as mouse or rat DNA microarrays are
used for the transcriptome profiling of Syrian hamster tissues and
Chinese hamster ovary cells [49]. For the microarray labeling
reaction, 200 ng of isolated RNA from each sample was used.
Labeling was done using the Low Input Quick Amp Labeling Kit
(Agilent Technologies, Santa Clara, CA) as per the manufacturer’s
protocol. Briefly, using affinity script-RT oligo dT promoter
primer, cDNA was generated and from the cDNA, labeled cRNA
was generated via an in vitro transcription reaction using T7 RNA
polymerase and Cy5 (DMBA, DMBA+chlorophyllin, DMBA+el-
lagic acid) or Cy3 (control) CTP. Labeled cRNA (825 ng) from
each sample was used for hybridization in the following
combinations- DMBA (Cy5) and control (Cy3), DMBA+chlor-
ophyllin (Cy5) and control (Cy3) and DMBA+ellagic acid (Cy5)
and control (Cy3). Hybridization was performed for 17 h, rotating
at a speed of 10 rpm at 65uC in a hybridization oven (Agilent
Technologies).
Microarray data analysis was done by using Limma package in
R-Bioconductor. Mean foreground and median background
expression values given by Agilent feature extraction Software
was used for analysis. Background subtraction was done using
‘‘subtract’’ method in Limma, dye normalization was done by
Figure 4. Relative mRNA expression levels of MMP-2, MMP-9, TIMP-2 and Cyclin D1 in various experimental groups as determined
by RT-qPCR. cDNA individually generated from the buccal pouch RNA of biological replicates was subjected to RT-qPCR analysis. Relative mRNA
expression for each gene was determined and normalized to the average transcript expression of GAPDH internal control. The fold change in
transcript expression for each gene was determined using the 2
2DDCt method. Data are the mean 6 SD of two separate experiments. Statistical
significance was determined by Mann-Whitney test (P,0.05). a Significantly different from control. b Significantly different from DMBA.
doi:10.1371/journal.pone.0034628.g004
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‘‘quantile’’ method. Imfit and eBayes (Empirical Bayes method)
were used to find differentially regulated genes. P value correction
was done using Benjamini and Hochberg method. P value cutoff
was made as 0.05. Gene enrichment analysis of the differentially
regulated genes with two-fold change cut off was done using
GSEA Pre Ranked Tool.
Quantitative Real-Time PCR for microarray data
validation
Total RNA from the hamster buccal pouch tissues of two
individual hamsters in each experimental group was extracted
using trizol reagent as described previously [48]. RNA was treated
with ribonuclease free DNaseI to remove any contaminating
DNA. Reverse transcription of 5 mg total RNA was performed
using the oligo-dT primers. Real-time RT-PCR was performed for
nine randomly chosen genes of interest as previously described
using a Step One Plus thermocycler (Applied Biosystems). The
PCR conditions were as follows: 95uC for 5 minutes, 40 cycles of
30 seconds at 95uC, 30 seconds at 60uC, 60 seconds at 72uC.
Relative quantitative fold change compared to control was
calculated using the comparative Ct method, where Ct is the
cycle number at which fluorescence first exceeds the threshold.
The Ct values from each sample were obtained by subtracting the
values for GAPDH Ct from the target gene Ct value. Specificity of
resulting PCR products was confirmed by melting curves.
Protein extraction and Western blotting
Approximately, 50 mg of buccal pouch tissue sample from two
hamsters in each experimental group was subjected to lysis in a
sample buffer containing 62.5 mM Tris (pH 6.8), 2% SDS, 5% 2-
mercaptoethanol, 10% glycerol and bromophenol blue. The
protein concentration of lysates was determined by Bradford
method. SDS-PAGE was performed using equivalent protein
Figure 5. Western blot analysis of the differentially expressed genes. (A) Representative immunoblots showing the protein levels of the
differentially expressed genes in the buccal pouch total cell lysate. Protein samples (50 mg/lane) resolved on SDS-PAGE were probed with
corresponding antibodies. Quantification was done by normalising the band density to that of b-actin. (B) Densitometric analysis. Each box plot
represents the protein expression from control lysates for two determinations. a Significantly different from control by Mann-Whitney test (P,0.05). b
Significantly different from DMBA.
doi:10.1371/journal.pone.0034628.g005
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electrophoretically transferred to polyvinylidene difluoride mem-
branes. The blots were incubated in 16PBS containing 5% non-
fat dry milk for 2 hours to block nonspecific binding sites. The blot
was incubated with 1:200 dilution of primary antibodies overnight
at 4uC. After washing, the blots were incubated with 1:1000
dilution of horseradish peroxidase-conjugated secondary antibody
for 45 min at room temperature. After extensive washes with high
and low salt buffers, the immunoreactive proteins were visualized
using enhanced chemiluminescence detection reagents (Sigma).
Statistical analysis
Statistical analysis was carried out using a nonparametric
Mann-Whitney test (Statsdirect, United Kingdom). A probability
value of less than 0.05 was considered significant.
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